Digital Penicillin Production

For thousands of years, micro-organisms have been used to facilitate chemical reactions - in beer brewing, for example. However, biochemical processes are incredibly complex, with a multitude of reactions taking place simultaneously and influencing one another. There are countless parameters that play a role, not all of which can be directly measured.

Despite the difficulties involved, researchers at TU Wien are now working on examining these processes in detail. Now, in cooperation with pharmaceutical manufacturer Sandoz, TU Wien has succeeded in analysing and comprehensively replicating a penicillin production process using a computer model. This process has even enabled researchers to determine parameters that cannot be measured directly. Sandoz is now making use of these findings to keep a full overview of the processes in the bioreactor at all times, ensuring optimum quality.

Black box replaced by in-depth knowledge

Many chemical reactions are easy to understand: if hydrogen is burned with oxygen, water is produced - in a clearly predictable manner and in a volume that can be precisely calculated beforehand. But how can you calculate how quickly a fungus will grow and proliferate under the constantly changing conditions in a bioreactor?

"For a long time, processes like this were seen as a 'black box' that cannot be understood and that can only be effectively exploited with a lot of experience," says Prof. Christoph Herwig, who leads the research group for bioprocess technology at TU Wien's Institute of Chemical, Environmental and Bioscience Engineering. "Our approach is somewhat different: we want to analyse the chemical processes in a bioreactor in detail and determine the equations that describe these processes." The aim is to produce a mathematical model that accurately replicates these processes within the bioreactor.

"Many parameters that are vital to the process simply cannot be directly measured, such as the growth rate of the micro-organisms," explains Julian Kager, who is working with Sandoz GmbH as part of his dissertation. "This is precisely why a comprehensive mathematical model is so useful: we use accessible data from the production process in real time, such as the concentration of various substances in the bioreactor, and use our computer model to calculate the most probable state of the process." The parameters that can't be measured can therefore be calculated.

The model information can be used to optimise the nutrient supply to the cultivated cells while the process is ongoing.

The system of equations used to mathematically describe the bioprocess is as complex and multifaceted as the process itself. "The system of equations describes a non-linear dynamic system. Even the smallest variations in the starting conditions can have a huge impact," explains Kager. "This means it's not really possible to simply work out a solution by hand; instead, relatively elaborate computer simulations are required to obtain the needed results."

The process model and algorithms developed at TU Wien are now being used by Sandoz GmbH for its penicillin production process. "We are very pleased that our basic research has been adopted for use in industry so quickly and that our approach of biochemical modelling is now being used to facilitate the automated control of pharmaceutical production processes," says Julian Kager.

Julian Kagera, Christoph Herwigab, Ines Viktoria Stelzercd.
State estimation for a penicillin fed-batch process combining particle filtering methods with online and time delayed offline measurements.
Chemical Engineering Science, Volume 177, 23 February 2018, Pages 234-244. doi: 10.1016/j.ces.2017.11.049.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...